Animal Healthcare Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
Global Animal Healthcare Market size is projected to expand at a 6% CAGR from 2024 to 2032, led by innovations and rising veterinary care expenditures.
New technologies and treatments are emerging to enhance the management and prevention of diseases in animals. There is consistent development of advanced diagnostics, vaccines, and therapeutic solutions to tackle a broad spectrum of health concerns. As expenditures on veterinary care rise, there's an increasing emphasis on delivering top-notch and comprehensive care for both pets and livestock.
In March 2024, the World Veterinary Association, in collaboration with Brooke, unveiled the inaugural essential veterinary medicines list (EVML) tailored for food-producing animals. This groundbreaking initiative aims to bolster animal healthcare by providing a comprehensive guide to essential medicines for maintaining animal health and welfare.
The overall market is segmented by product, animal type, distribution channel, and region.
Based on product, the animal healthcare market value from the pharmaceuticals segment is projected to rise significantly from 2024 to 2032, driven by the increasing demand for advanced treatments and medications to manage and prevent diseases in animals. Pharmaceuticals include vaccines, antibiotics, and specialized drugs designed to address a wide range of health issues in both companion animals and livestock. The focus is on developing pharmaceuticals that improve efficacy, safety, and ease of administration, ensuring better health outcomes for animals.
The animal healthcare industry share from the e-commerce distribution channel segment is anticipated to expand at a notable rate until 2032, owing to the need for convenient access to a wide range of veterinary products and services. E-commerce channels enable pet owners and livestock managers to easily purchase medications, supplements, and other healthcare items online, streamlining the process of obtaining essential products. Online platforms are expanding their offerings to include not only pharmaceuticals but also diagnostic tools and preventive care solutions.
MEA animal healthcare market size is projected to depict robust growth by 2032, driven by the expansion of livestock farming. There is an increasing demand for comprehensive health management solutions to ensure the well-being and productivity of animals. Enhanced animal healthcare products and services are being developed to address the needs of larger and more diverse livestock populations. Ongoing research and development will advance animal health management, supporting the sustainability and efficiency of expanding livestock farming practices in the region.
Global Animal Healthcare Market size is projected to expand at a 6% CAGR from 2024 to 2032, led by innovations and rising veterinary care expenditures. New technologies and treatments are emerging to enhance the management and prevention of diseases in animals. There is consistent development of advanced diagnostics, vaccines, and therapeutic solutions to tackle a broad spectrum of health concerns. As expenditures on veterinary care rise, there's an increasing emphasis on delivering top-notch and comprehensive care for both pets and livestock. In March 2024, the World Veterinary Association, in collaboration with Brooke, unveiled the inaugural essential veterinary medicines list (EVML) tailored for food-producing animals. This groundbreaking initiative aims to bolster animal healthcare by providing a comprehensive guide to essential medicines for maintaining animal health and welfare. The overall market is segmented by product, animal type, distribution channel, and region. Based on product, the animal healthcare market value from the pharmaceuticals segment is projected to rise significantly from 2024 to 2032, driven by the increasing demand for advanced treatments and medications to manage and prevent diseases in animals. Pharmaceuticals include vaccines, antibiotics, and specialized drugs designed to address a wide range of health issues in both companion animals and livestock. The focus is on developing pharmaceuticals that improve efficacy, safety, and ease of administration, ensuring better health outcomes for animals. The animal healthcare industry share from the e-commerce distribution channel segment is anticipated to expand at a notable rate until 2032, owing to the need for convenient access to a wide range of veterinary products and services. E-commerce channels enable pet owners and livestock managers to easily purchase medications, supplements, and other healthcare items online, streamlining the process of obtaining essential products. Online platforms are expanding their offerings to include not only pharmaceuticals but also diagnostic tools and preventive care solutions. MEA animal healthcare market size is projected to depict robust growth by 2032, driven by the expansion of livestock farming. There is an increasing demand for comprehensive health management solutions to ensure the well-being and productivity of animals. Enhanced animal healthcare products and services are being developed to address the needs of larger and more diverse livestock populations. Ongoing research and development will advance animal health management, supporting the sustainability and efficiency of expanding livestock farming practices in the region.
- Chapter 1 Methodology and Scope
- 1.1 Market scope and definitions
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
- Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
- Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing population of pet animals
- 3.2.1.2 Increasing support offered by government and public organizations for animal care
- 3.2.1.3 Growing demand for online veterinary pharmacies
- 3.2.1.4 Increase in animal healthcare expenditure
- 3.2.2 Industry pitfalls and challenges
- 3.2.2.1 High cost associated with animal health drugs
- 3.2.2.2 Limited access in rural areas
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.1.1 U.S.
- 3.4.1.2 Canada
- 3.4.2 European Union
- 3.4.3 Asia Pacific
- 3.4.3.1 Japan
- 3.4.3.2 China
- 3.5 Technology landscape
- 3.6 Reimbursement scenario
- 3.7 Venture capitalist scenario in animal health industry
- 3.8 Economic impacts of the animal health industry
- 3.9 Gap analysis
- 3.10 Consumer behaviour trends
- 3.11 Porter's analysis
- 3.12 PESTEL analysis
- Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
- Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Pharmaceuticals
- 5.2.1 Drugs
- 5.2.1.1 Antiparasitic
- 5.2.1.2 Anti-inflammatory
- 5.2.1.3 Anti-infectives
- 5.2.1.4 Other drugs
- 5.2.2 Vaccines
- 5.2.2.1 Modified live vaccines (MLV)
- 5.2.2.2 Killed inactivated vaccines
- 5.2.2.3 Other vaccines
- 5.2.3 Medicated feed additives
- 5.2.3.1 Antibiotics
- 5.2.3.2 Vitamins
- 5.2.3.3 Amino acids
- 5.2.3.4 Enzymes
- 5.2.3.5 Antioxidants
- 5.2.3.6 Prebiotics and probiotics
- 5.2.3.7 Minerals
- 5.2.3.8 Other medicated feed additives
- 5.3 Medical devices
- 5.3.1 Veterinary diagnostic equipment
- 5.3.2 Veterinary anesthesia equipment
- 5.3.3 Veterinary patient monitoring equipment
- 5.3.4 Veterinary surgical equipment
- 5.3.5 Veterinary consumables
- 5.3.6 Other medical devices
- 5.4 Veterinary services
- Chapter 6 Market Estimates and Forecast, By Animal Type, 2018 – 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Companion animals
- 6.2.1 Dogs
- 6.2.2 Cats
- 6.2.3 Horses
- 6.2.4 Other companion animals
- 6.3 Livestock animals
- 6.3.1 Poultry
- 6.3.2 Swine
- 6.3.3 Cattle
- 6.3.4 Fish
- 6.3.5 Other livestock animals
- Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
- 7.1 Key trends
- 7.2 Veterinary hospital pharmacy
- 7.3 E-commerce
- 7.4 Retail pharmacy
- Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Poland
- 8.3.7 Netherlands
- 8.3.8 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Taiwan
- 8.4.7 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 GCC Countries
- 8.6.3 Israel
- 8.6.4 Rest of Middle East and Africa
- Chapter 9 Company Profiles
- 9.1 B. Braun Vet Care (B Braun Melsungen AG)
- 9.2 Boehringer Ingelheim International GmbH
- 9.3 Ceva Sante Animale
- 9.4 Dechra Pharmaceuticals
- 9.5 Elanco Animal Health
- 9.6 Endovac Animal Health
- 9.7 HIPRA
- 9.8 IDEXX Laboratories
- 9.9 Merck and Co
- 9.10 Medtronic plc
- 9.11 Neogen Corporation
- 9.12 Sklar Surgical Instruments
- 9.13 Symrise
- 9.14 Vetoquinol SA
- 9.15 Virbac SA
- 9.16 Zoetis, Inc.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook